OPNT logo

Opiant Pharmaceuticals (OPNT) Revenue

Annual Revenue

$40.73 M
+$13.32 M+48.62%

December 31, 2021

Summary

Performance

1-Year Change

+48.62%

3-Year Change

+201.38%

5-Year Change

+246.24%

15-Year Change

+246.24%

OPNT Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Analysts Estimate

$9.00 M
OPNT annual revenue is currently +352.50% higher than the consensus analysts' forecast

High & Low

All-time High

$40.73 M
OPNT annual revenue is currently at an all-time high

3-Year Low

$40.73 M
OPNT annual revenue is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2021
OPNT previous annual earnings announcement was published on Dec 31, 2021

Next Annual Earnings Report Date

N/A
OPNT next annual earnings announcement has not yet been scheduled

OtherOPNTprofitabilitymetrics:

Annual EPS

$0.51
OPNT annual earnings per share is $0.51

Annual Net Income

$3.01 M
OPNT annual net profit is $3.01 million

Annual Operating Profit

$5.16 M
OPNT annual operating income is $5.16 million

Annual Gross Profit

$31.66 M
OPNT annual gross profit is $31.66 million

Quarterly Revenue

N/A

September 30, 2022

Summary

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

OPNT Quarterly Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Analysts Estimate

$1.80 M
OPNT quarterly revenue is currently equal to the consensus analysts' forecast

High & Low

All-time High

$20.49 M
OPNT quarterly revenue is currently at an all-time high

3-Year Low

$2.19 M
OPNT quarterly revenue is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2022
OPNT previous earnings announcement was published on Sep 30, 2022

Next Quarterly Earnings Report Date

N/A
OPNT next earnings announcement has not yet been scheduled

Related metrics

Quarterly Gross Profit

$0.00
OPNT quarterly gross profit is $0.00

Quarterly Operating Profit

-$9.63 M
OPNT quarterly operating income is -$9.63 million

Quarterly Net Income

-$9.92 M
OPNT quarterly net profit is -$9.92 million

Quarterly EPS

-$1.93
OPNT quarterly earnings per share is -$1.93

TTM Revenue

N/A

September 30, 2022

Summary

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

OPNT TTM Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Analysts Estimate

$6.32 M
OPNT TTM revenue is currently equal to the consensus analysts' forecast

High & Low

All-time High

$40.73 M
OPNT TTM revenue is currently at an all-time high

3-Year Low

$31.60 M
OPNT TTM revenue is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2022
OPNT previous earnings announcement was published on Sep 30, 2022

Next Quarterly Earnings Report Date

N/A
OPNT next earnings announcement has not yet been scheduled

OtherOPNTprofitabilitymetrics:

TTM Gross Profit

$13.69 M
OPNT TTM gross profit is $13.69 million

TTM Operating Profit

-$31.51 M
OPNT TTM operating income is -$31.51 million

TTM Net Income

-$33.09 M
OPNT TTM net profit is -$33.09 million

TTM EPS

-$6.57
OPNT TTM earnings per share is -$6.57

OPNT Revenue Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+48.6%--
3 y3 years+201.4%--
5 y5 years+246.2%--

OPNT Revenue Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat highat low
5 y5-yearat high-32.7%
alltimeall timeat high-96.2%

Opiant Pharmaceuticals Revenue History

DateAnnualQuarterlyTTM
Jun 2022
-
$2.33 M(+6.1%)
$31.60 M(-18.1%)
Mar 2022
-
$2.19 M(-83.2%)
$38.58 M(-5.3%)
Dec 2021
$40.73 M(+48.6%)
$13.04 M(-7.2%)
$40.73 M(+13.0%)
Sep 2021
-
$14.04 M(+50.7%)
$36.03 M(+17.8%)
Jun 2021
-
$9.31 M(+114.9%)
$30.59 M(+11.1%)
Mar 2021
-
$4.33 M(-48.1%)
$27.54 M(+0.5%)
Dec 2020
$27.40 M(-28.3%)
$8.34 M(-3.0%)
$27.40 M(+4.3%)
Sep 2020
-
$8.60 M(+37.4%)
$26.28 M(-31.2%)
Jun 2020
-
$6.26 M(+49.0%)
$38.17 M(-1.1%)
Mar 2020
-
$4.20 M(-41.9%)
$38.61 M(+1.0%)
Dec 2019
$38.24 M(+183.0%)
$7.22 M(-64.8%)
$38.24 M(+7.8%)
Sep 2019
-
$20.49 M(+206.2%)
$35.47 M(+84.5%)
Jun 2019
-
$6.69 M(+74.9%)
$19.22 M(+22.9%)
Mar 2019
-
$3.83 M(-14.1%)
$15.64 M(+15.7%)
Dec 2018
$13.51 M
$4.46 M(+4.9%)
$13.51 M(+49.2%)
DateAnnualQuarterlyTTM
Sep 2018
-
$4.25 M(+36.8%)
$9.06 M(+87.5%)
Jun 2018
-
$3.11 M(+82.4%)
$4.83 M(-12.1%)
Mar 2018
-
$1.70 M(+7640.9%)
$5.50 M(-68.3%)
Dec 2017
$11.76 M(-36.2%)
-
-
Oct 2017
-
$22.00 K(-99.4%)
$17.35 M(-6.0%)
Jul 2017
$18.45 M(+86.4%)
$3.77 M(>+9900.0%)
$18.45 M(+23.1%)
Apr 2017
-
$18.10 K(-99.9%)
$14.99 M(-14.7%)
Jan 2017
-
$13.54 M(+1107.4%)
$17.57 M(+61.2%)
Oct 2016
-
$1.12 M(+258.7%)
$10.90 M(+10.1%)
Jul 2016
$9.90 M(+538.6%)
$312.50 K(-88.0%)
$9.90 M(-5.3%)
Apr 2016
-
$2.61 M(-62.0%)
$10.46 M(+31.2%)
Jan 2016
-
$6.86 M(+5616.7%)
$7.97 M(+377.2%)
Oct 2015
-
$120.00 K(-86.2%)
$1.67 M(+7.7%)
Jul 2015
$1.55 M
$870.00 K(+625.0%)
$1.55 M(+127.9%)
Apr 2015
-
$120.00 K(-78.6%)
$680.00 K(+21.4%)
Jan 2015
-
$560.00 K
$560.00 K

FAQ

  • What is Opiant Pharmaceuticals annual revenue?
  • What is the all time high annual revenue for Opiant Pharmaceuticals?
  • What is Opiant Pharmaceuticals annual revenue year-on-year change?
  • What is the all time high quarterly revenue for Opiant Pharmaceuticals?
  • What is the all time high TTM revenue for Opiant Pharmaceuticals?

What is Opiant Pharmaceuticals annual revenue?

The current annual revenue of OPNT is $40.73 M

What is the all time high annual revenue for Opiant Pharmaceuticals?

Opiant Pharmaceuticals all-time high annual revenue is $40.73 M

What is Opiant Pharmaceuticals annual revenue year-on-year change?

Over the past year, OPNT annual revenue has changed by +$13.32 M (+48.62%)

What is the all time high quarterly revenue for Opiant Pharmaceuticals?

Opiant Pharmaceuticals all-time high quarterly revenue is $20.49 M

What is the all time high TTM revenue for Opiant Pharmaceuticals?

Opiant Pharmaceuticals all-time high TTM revenue is $40.73 M